Confronto
Mazdutide vs. Pramlintid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Metabolico
Metabolico
N. CAS
2259884-03-0
151126-32-8
Peso molecolare
4790 g/mol
3949.4 g/mol
Emivita
132 h
nessun dato
Sequenza
synthetisches Oxyntomodulin-Analogon (39 Aminosäuren) mit Fettsäureseitenkettenessun dato
Meccanismo d'azione
Mazdutide
Mazdutide is a dual agonist at the GLP-1 and glucagon receptors and is structurally derived from the gut hormone oxyntomodulin. The GLP-1 component mediates glucose-dependent insulin secretion, inhibition of glucagon secretion at elevated blood glucose, and modulation of appetite and gastric emptying. The glucagon component can influence energy expenditure and hepatic lipid and glucose metabolism. A fatty-acid side chain enables albumin binding and the weekly administration interval.
Pramlintid
Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
4
0
di cui sull'uomo
4
0
Effetti registrati
4
2
Contraddizioni aperte
0
1
Eventi avversi documentati
0
2
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Mazdutide and Pramlintid?
- Mazdutide is classified as "Metabolico", while Pramlintid is classified as "Metabolico". Mazdutide: Synthetic oxyntomodulin analogue that simultaneously activates the GLP-1 and glucagon receptors (dual agonist). Developed by Innovent Biologics and Eli Lilly. In China the NMPA approved mazdutide on 27 June 2025 for chronic weight management; a further filing for type 2 diabetes is under review in China. Outside China the substance remains in clinical development. Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Mazdutide or Pramlintid?
- The highest available evidence level is "RCT sull'uomo" for Mazdutide and "RCT sull'uomo" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Mazdutide and Pramlintid in Germany and the United States?
- Germania: Mazdutide — Solo ricerca, Pramlintid — Non approvato. Stati Uniti: Mazdutide — Solo ricerca, Pramlintid — Su prescrizione. These are factual summaries with source and review date on the individual pages.